Deal strengthens ContextVision’s position in the global ultrasound market
STOCKHOLM – April 25, 2016 – ContextVision, the leading provider of medical image processing software, has expanded their partnership with a global ultrasound manufacturer in March, adding both 2D and 3D ultrasound imaging to the existing, long-term agreement. This expansion broadens ContextVision within the 2D and 3D mid-range segment.
Image quality is required for clinical accuracy and is no longer found in only high-end products. Now, one of the major global players in the space is raising the bar for image quality in the mid-end segment. This new customer will add US PLUSView™ and GOPiCE® US to their current agreement with ContextVision.
US PLUSView™ is the state of the art image enhancement software for 2D ultrasound. Its flexibility make it possible to improve the image quality significantly across the entire range of ultrasound systems and applications.
GOPiCE® US is the only image enhancement software for volumetric ultrasound (3D/4D) available on the market. This software is optimized for both 3D/4D rendered images and MPR views. The advanced volumetric contrast enhancement and noise suppression enables the highest diagnostic confidence for clinicians.
“I’m very pleased our collaboration with this ultrasound customer is expanding,” shared Fredrik Palm, Vice President – OEM Business, ContextVision. “It once again proves the added value we bring to our customers.”
ContextVision’s medical imaging technology is at the forefront of the industry, allowing OEMs to deliver excellent image quality to the market. This, in turn, puts powerful technology in the hands of clinicians that will allow them to make more accurate and faster diagnoses. With ultrasound expertise and proprietary technology, ContextVision is the ultimate imaging partner for today and the future.
ContextVision is a medical technology company specializing in image analysis and image processing. Its cutting-edge technology helps doctors more accurately interpret medical images, a crucial foundation for better diagnosis and treatment. As an industry pioneer for more than 30 years, ContextVision has decided to take a lead position within deep learning, the latest technology within artificial intelligence. ContextVision is currently investing heavily in this field to develop a broader product portfolio. The present product portfolio includes state-of-the-art image enhancement software for 2D/3D/4D ultrasound, MRI, X-ray and mammography and is used by leading equipment manufacturers worldwide. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.
Phone: +46 76 870 25 43
Operator: +46 8 750 35 50